CD274 and neoplasm: Several biomarkers, including PD-L1 expression, microsatellite instability (MSI)/deficient mismatch repair (dMMR), tumor mutational burden (TMB), and the presence of tumor-infiltrating lymphocytes (TILs), have been identified as potential predictors of response to ICIs in other solid tumors [9,10,11,12].